← All trials
NCT05107934
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2022
- Primary completion
- May 1, 2025
- Completion date
- Oct 1, 2025
- First posted
- Nov 4, 2021
- Last posted
- Nov 4, 2021
- Enrollment
- 80
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- R-PharmLead sponsor
- R-PharmStudy director
- Data Management 365 LLCCollaborator
- KeystatCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.